Improve adherence and persistence
Wrap oral oncology therapies in a home monitoring layer.
At-home CBC testing on Algocyte Proxima, symptom capture and automated reminders keep patients engaged with their therapy, and on it, longer.
Meet ProximaFor pharma-sponsored oncology programmes
Keep patients on therapy, longer.
Algocyte gives pharma-sponsored oncology programmes longitudinal CBC and symptom intelligence, protecting adherence and generating real-world evidence.
What it unlocks for sponsors
Higher
Adherence and persistence on therapy
Fewer
Treatment interruptions and dose reductions
RWE
Real-world evidence over time
The problem
Patient support programmes are flying blind between visits.
Infrequent monitoring
Nurse calls and periodic blood tests leave little visibility between appointments.
Delayed intervention
Toxicity is detected after treatment has already been disrupted.
Limited biomarker intelligence
Programmes rely heavily on patient self-report rather than objective signal.
Low personalisation
Monitoring is protocol-based, not patient-specific.
Generate longitudinal patient intelligence
Real-world evidence over time.
Regular CBC and symptom data create a longitudinal patient intelligence layer, richer programme visibility today, stronger RWE downstream.
Inside Health HubHow a partnership runs.
01
Scope the programme
Co-design cohort, cadence and endpoints with our scientific team.
02
Deploy at home
Devices ship direct to enrolled patients with remote onboarding.
03
Monitor regularly
AI-supported alerts route into your existing patient-support workflows.
04
Analyse together
Joint review of adherence, persistence and clinical RWE signal.
Built for everyone in the room.
For you & your family
Personal health intelligence, in one place you control.
Learn moreProviders
NHS oncology programs and dashboards with EHR integration in development.
Learn morePayors
Outcome data for value-based contracts and lower acute spend.
Learn morePsychiatry
Clozapine monitoring in the community.
Learn moreBring regular immune monitoring to your patients.
Book a 20-minute briefing with our clinical team to see Algocyte in action.